Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2020
High FLT3 Levels May Predict Sorafenib Benefit in Hepatocellular CarcinomaWen Sun, Shi-Chao Li, Li Xu, et al.
Hepatology (Baltimore, Md.)|May 13, 2015
Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1Sheng-xian Yuan, Jie Wang, Fu Yang, et al.
Frontiers in Immunology|January 2, 2023
Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell-mediated antitumor activityHao Zheng, Wen-Juan Zheng, Zhen-Guang Wang, et al.
Frontiers in Immunology|February 14, 2022
Decreased Expression of Programmed Death Ligand-L1 by Seven in Absentia Homolog 2 in Cholangiocarcinoma Enhances T-Cell-Mediated Antitumor ActivityHao Zheng, Wen-Juan Zheng, Zhen-Guang Wang, et al.
International Journal of Biological Sciences|March 16, 2023
N6-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone MetastasisHao Zheng, Zhang-Jun Cheng, Bo Liang, et al.
Oncotarget|September 24, 2016
Paraoxonase 3 inhibits cell proliferation and serves as a prognostic predictor in hepatocellular carcinomaJie Cai, Sheng-Xian Yuan, Fu Yang, et al.
Oncotarget|October 4, 2016
eIF5B increases ASAP1 expression to promote HCC proliferation and invasionZhen-Guang Wang, Hao Zheng, Wei Gao, et al.
Molecular Cancer|September 18, 2015
Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinomaQi-Fei Tao, Sheng-Xian Yuan, Fu Yang, et al.
Oncotarget|January 26, 2017
CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinomaHao Zheng, Wei-Hua Jiang, Tao Tian, et al.
Journal of Hepatology|January 18, 2019
A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinomaQing-Guo Xu, Sheng-Xian Yuan, Qi-Fei Tao, et al.
Pageof 5